Relentless pursuit of therapeutics

that slow/stop the progression of Parkinson's disease

Technology

Vincere's pipeline of small molecules is founded on a platform of molecular mechanisms implicated in pathogenesis of Parkinson's disease through an exclusive license to patented simulation of human data & AI from:




Funding

Support for Vincere's discovery platform and pipeline provided by private investors and:


 

More info: investor@VincereBio.com.

Pipeline

Multiple programs are underway to restore mitochondrial health in Parkinson's disease and related neurodegenerative disorders.